FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4243233769> ?p ?o ?g. }

• W4243233769 abstract "Background Fluoroquinolones are sometimes used to treat multiple‐drug‐resistant and drug‐sensitive tuberculosis. The effects of fluoroquinolones in tuberculosis regimens need to be assessed. Objectives To assess fluoroquinolones as additional or substitute components to antituberculous drug regimens for drug‐sensitive and drug‐resistant tuberculosis. Search methods In July 2007, we searched the Cochrane Infectious Diseases Group Specialized Register, CENTRAL (The Cochrane Library 2007, Issue 3), MEDLINE, EMBASE, LILACS, Science Citation Index, Database of Russian Publications, and metaRegister of Controlled Trials. We also scanned reference lists of all identified studies and contacted researchers. Selection criteria Randomized controlled trials of antituberculous regimens containing fluoroquinolones in people diagnosed with bacteriologically positive (sputum smear or culture) pulmonary tuberculosis. Data collection and analysis Two authors independently applied inclusion criteria, assessed the risk of bias in the trials, and extracted data. We used risk ratio (RR) for dichotomous data, mean difference (MD) for continuous data (both with 95% confidence intervals (CI)), and the random‐effects model if we detected heterogeneity and it was appropriate to combine data. Main results Eleven trials (1514 participants) met the inclusion criteria. No statistically significant difference was found in trials substituting ciprofloxacin, ofloxacin or moxifloxacin for first‐line drugs in relation to cure (416 participants, 3 trials), treatment failure (388 participants, 3 trials), or clinical or radiological improvement (216 participants, 2 trials). Substituting ciprofloxacin into first‐line regimens in drug‐sensitive tuberculosis led to a higher incidence of relapse (RR 7.17, 95% CI 1.33 to 38.58; 384 participants, 3 trials) and longer time to sputum culture conversion (MD 0.50 months, 95% CI 0.18 to 0.82; 168 participants, 1 trial), although this was confined to HIV‐positive participants. Substituting for ethambutol in first‐line regimens led to a higher incidence of total number of adverse events (RR 1.34, 95% CI 1.05 to 1.72; 492 participants, 2 trials). Adding or substituting levofloxacin to basic regimens in drug‐resistant areas had no effect. A comparison of sparfloxacin versus ofloxacin added to regimens showed no statistically significant difference in cure (184 participants, 2 trials), treatment failure (149 participants, 2 trials), or the total number of adverse events (253 participants, 3 trials). Authors' conclusions Only ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin have been tested in randomized controlled trials for treating tuberculosis. We cannot recommend ciprofloxacin in treating tuberculosis. Trials of newer fluoroquinolones for treating tuberculosis are needed and are ongoing. No difference has been demonstrated between sparfloxacin and ofloxacin in drug‐resistant tuberculosis." @default.
• W4243233769 created "2022-05-12" @default.
• W4243233769 creator A5013868193 @default.
• W4243233769 creator A5023828847 @default.
• W4243233769 date "2008-01-23" @default.
• W4243233769 modified "2023-10-10" @default.
• W4243233769 title "Fluoroquinolones for treating tuberculosis" @default.
• W4243233769 cites W1966126698 @default.
• W4243233769 cites W1966820980 @default.
• W4243233769 cites W1967748659 @default.
• W4243233769 cites W1986822335 @default.
• W4243233769 cites W1996896990 @default.
• W4243233769 cites W1996930122 @default.
• W4243233769 cites W2000452767 @default.
• W4243233769 cites W2013369772 @default.
• W4243233769 cites W2019023077 @default.
• W4243233769 cites W2032342750 @default.
• W4243233769 cites W2032353669 @default.
• W4243233769 cites W2033890227 @default.
• W4243233769 cites W2045865641 @default.
• W4243233769 cites W2047505716 @default.
• W4243233769 cites W2047606924 @default.
• W4243233769 cites W2061088592 @default.
• W4243233769 cites W2065376976 @default.
• W4243233769 cites W2070043025 @default.
• W4243233769 cites W2079152792 @default.
• W4243233769 cites W2080750733 @default.
• W4243233769 cites W2082004384 @default.
• W4243233769 cites W2095037435 @default.
• W4243233769 cites W2095544141 @default.
• W4243233769 cites W2102212813 @default.
• W4243233769 cites W2106949433 @default.
• W4243233769 cites W2108206593 @default.
• W4243233769 cites W2118660489 @default.
• W4243233769 cites W2135989318 @default.
• W4243233769 cites W2144010669 @default.
• W4243233769 cites W2147445933 @default.
• W4243233769 cites W2149860604 @default.
• W4243233769 cites W2153938082 @default.
• W4243233769 cites W2155336089 @default.
• W4243233769 cites W2158658436 @default.
• W4243233769 cites W2159470927 @default.
• W4243233769 cites W2162098313 @default.
• W4243233769 cites W2418210342 @default.
• W4243233769 cites W4232723310 @default.
• W4243233769 cites W4238748109 @default.
• W4243233769 doi "https://doi.org/10.1002/14651858.cd004795.pub3" @default.
• W4243233769 hasPublicationYear "2008" @default.
• W4243233769 type Work @default.
• W4243233769 citedByCount "24" @default.
• W4243233769 countsByYear W42432337692012 @default.
• W4243233769 countsByYear W42432337692013 @default.
• W4243233769 countsByYear W42432337692015 @default.
• W4243233769 countsByYear W42432337692016 @default.
• W4243233769 countsByYear W42432337692019 @default.
• W4243233769 countsByYear W42432337692021 @default.
• W4243233769 countsByYear W42432337692022 @default.
• W4243233769 crossrefType "reference-entry" @default.
• W4243233769 hasAuthorship W4243233769A5013868193 @default.
• W4243233769 hasAuthorship W4243233769A5023828847 @default.
• W4243233769 hasConcept C126322002 @default.
• W4243233769 hasConcept C142724271 @default.
• W4243233769 hasConcept C168563851 @default.
• W4243233769 hasConcept C17744445 @default.
• W4243233769 hasConcept C199539241 @default.
• W4243233769 hasConcept C2776301714 @default.
• W4243233769 hasConcept C2776478404 @default.
• W4243233769 hasConcept C2777768864 @default.
• W4243233769 hasConcept C2778836808 @default.
• W4243233769 hasConcept C2779473830 @default.
• W4243233769 hasConcept C2781069245 @default.
• W4243233769 hasConcept C44249647 @default.
• W4243233769 hasConcept C501593827 @default.
• W4243233769 hasConcept C535046627 @default.
• W4243233769 hasConcept C71924100 @default.
• W4243233769 hasConcept C82789193 @default.
• W4243233769 hasConcept C86803240 @default.
• W4243233769 hasConcept C89423630 @default.
• W4243233769 hasConcept C95190672 @default.
• W4243233769 hasConceptScore W4243233769C126322002 @default.
• W4243233769 hasConceptScore W4243233769C142724271 @default.
• W4243233769 hasConceptScore W4243233769C168563851 @default.
• W4243233769 hasConceptScore W4243233769C17744445 @default.
• W4243233769 hasConceptScore W4243233769C199539241 @default.
• W4243233769 hasConceptScore W4243233769C2776301714 @default.
• W4243233769 hasConceptScore W4243233769C2776478404 @default.
• W4243233769 hasConceptScore W4243233769C2777768864 @default.
• W4243233769 hasConceptScore W4243233769C2778836808 @default.
• W4243233769 hasConceptScore W4243233769C2779473830 @default.
• W4243233769 hasConceptScore W4243233769C2781069245 @default.
• W4243233769 hasConceptScore W4243233769C44249647 @default.
• W4243233769 hasConceptScore W4243233769C501593827 @default.
• W4243233769 hasConceptScore W4243233769C535046627 @default.
• W4243233769 hasConceptScore W4243233769C71924100 @default.
• W4243233769 hasConceptScore W4243233769C82789193 @default.
• W4243233769 hasConceptScore W4243233769C86803240 @default.
• W4243233769 hasConceptScore W4243233769C89423630 @default.
• W4243233769 hasConceptScore W4243233769C95190672 @default.
• W4243233769 hasLocation W42432337691 @default.
• W4243233769 hasOpenAccess W4243233769 @default.

• next